Literature DB >> 18165635

Randomized trials in oncology stopped early for benefit.

Ryan A Wilcox1, Benjamin Djulbegovic, H Lee Moffitt, Gordon H Guyatt, Victor M Montori.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18165635     DOI： 10.1200/JCO.2007.13.6259

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.

Authors:  Edward L Korn; Boris Freidlin; Margaret Mooney
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

2.  Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124.

Authors:  Primo N Lara; Kari Chansky; Taro Shibata; Haruhiko Fukuda; Tomohide Tamura; John Crowley; Mary W Redman; Ronald Natale; Nagahiro Saijo; David R Gandara
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

3.  Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.

Authors:  J Younus; S Verma; J Franek; N Coakley
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

4.  Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

Authors:  Primo N Lara; Ronald Natale; John Crowley; Heinz Josef Lenz; Mary W Redman; Jane E Carleton; James Jett; Corey J Langer; J Philip Kuebler; Shaker R Dakhil; Kari Chansky; David R Gandara
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

5.  Multiple treatment comparison meta-analyses: a step forward into complexity.

Authors:  Edward J Mills; Nick Bansback; Isabella Ghement; Kristian Thorlund; Steven Kelly; Milo A Puhan; James Wright
Journal:  Clin Epidemiol       Date:  2011-05-27       Impact factor: 4.790

6.  CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers.

Authors:  Wei-Fu Lv; Jian-Kui Han; De-Lei Cheng; Chun-Ze Zhou; Ming Ni; Dong Lu
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

Review 7.  A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.

Authors:  Ricardo M Fernandes; Johanna H van der Lee; Martin Offringa
Journal:  BMC Pediatr       Date:  2009-12-13       Impact factor: 2.125

8.  Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.

Authors:  Munyaradzi Dimairo; Steven A Julious; Susan Todd; Jonathan P Nicholl; Jonathan Boote
Journal:  Trials       Date:  2015-12-23       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.